Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
New research from Denmark adds further weight to the idea that type 2 diabetes is an inflammatory disease.
The recently published study describes how in mice, during the very early stages of type 2 diabetes, immune cells called macrophages invade pancreatic tissue, releasing large quantities of cytokines - pro-inflammatory proteins - that help destroy insulin-producing beta cells.
More than 360 million people around the world have type 2 diabetes, including around 8% of Americans. The disease can lead to more serious conditions like cardiovascular disease, blindness, loss of limbs, and kidney failure.
In people who are healthy and do not have diabetes, the beta cells of the pancreas secrete insulin into the bloodstream - this helps to regulate blood sugar levels which rise after eating.
One of the researchers, Dr. Alexander Rosendahl, from the Department of Diabetes Complication Biology at Novo Nordisk A/S, in Malov, says:
"The study may provide novel insights allowing development of tailor-made anti-inflammatory based therapies reducing the burden of type 2 patients."
Such new treatments could be used to complement existing therapies, for example those that use insulin analogues, he adds.
For their study, Dr. Rosendahl and colleagues compared obese mice that spontaneously developed diabetes to normal healthy mice.
They observed the mice from a young age, when in early stages of obesity, until after their obesity in adulthood had started to affect multiple organs.
They monitored presence of macrophages around the insulin-producing beta cells of the pancreas, and also in the spleen. The advanced cytometric technology they used allowed them to take measurements at the level of single cells.
Their observations showed some significant differences in what happened to the islets of the pancreas (the
The authors write:
"Already at 8 weeks of disease, on average, 12 macrophages were observed in the diabetic islets, whereas only two were recorded in the nondiabetic littermates."
They note how in the older diabetic mice, the changes in the pancreas and spleen moved more toward a pro- inflammatory pattern:
"In late-stage diabetes, the cytokine signature changed toward a TGF-β-dominated profile, coinciding with a significant increase of galectin-3-positive macrophages in the spleen."
They say these findings show that proinflammatory macrophages invade diabetic islets.
Dr. John Wherry, deputy editor of the Journal of Leukocyte Biology that published the study, says:
"This study sheds light on how a key inflammatory cell is connected to disease and what might go wrong when someone has type 2 diabetes. The knowledge gained from such studies offers hope that new immune-based therapies could be developed to mitigate the severity of such dieseases."
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization; Helena Cucak, Lars Groth Grunnet and Alexander Rosendahl; Journal of Leukocyte Biology January 2014, vol. 95 no. 1 149-160; Abstract.
Additional source: Federation of American Societies for Experimental Biology news release via EurekAlert 2 January 2014.
Visit our Diabetes category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Paddock, Catharine. " Type 2 diabetes is an inflammatory disease, say researchers." Medical News Today. MediLexicon, Intl., 12 Jan. 2014. Web.
11 Mar. 2014. <http://www.medicalnewstoday.com/articles/270817>
Paddock, C. (2014, January 12). " Type 2 diabetes is an inflammatory disease, say researchers." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/270817.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.